Sichuan Goldstone Asia Pharmaceutical Inc. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was CNY 777.296 million compared to CNY 1,005.606 million a year ago. Operating loss was CNY 667.944 million compared to operating Income of CNY 160.570 million a year ago. Net loss was CNY 687.659 million compared to net income of CNY 120.334 million a year ago. Basic loss per share from continuing operations was CNY 1.71 compared to basic earnings per share from continuing operations of CNY 0.3 a year ago.